Deucravacitinib in Plaque Psoriasis: Maintenance of Response Over 4 Years in the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 4, p. s407, 2024. DOI: 10.25251/skin.8.supp.407. Disponível em: https://skin.dermsquared.com/skin/article/view/2856. Acesso em: 4 apr. 2025.